Louisiana Administrative Code
Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS
Part XLV - Medical Professions
Subpart 3 - Practice
Chapter 72 - Consultation or Collaboration with Medical Psychologists
Subchapter A - General Provisions
Section XLV-7203 - Definitions
Current through Register Vol. 50, No. 9, September 20, 2024
A. As used in this Chapter, the following words and terms shall have the meanings specified.
Active Clinical Relationship-shall mean that the physician has seen the patient professionally e.g., examined, diagnosed and/or treated the patient within the past 12 months.
Board- the Louisiana State Board of Medical Examiners, as constituted in the Act.
Concurrence or Concur-a physician's agreement to a plan for psychopharmacological management of a patient based on prior discussion with an MP.
Consultation and Collaboration with an MP or Consult and/or Collaborate- that practice in which a physician discusses and, if deemed appropriate, concurs in an MP's plan for psychopharmacologic management of a patient for whom the physician is the primary or attending physician.
Controlled Substance- any substance defined, enumerated, or included in federal or state statute or regulations 21 C.F.R. 1308.11 -.15 or R.S. 40:964, or any substance which may hereafter be designated as a controlled substance by amendment or supplementation of such regulations or statute.
Discussion-a communication between a physician and a medical psychologist conducted in person, by telephone, in writing or by some other appropriate means.
Drug- shall mean the same as the term "drug" as defined in R.S. 40:961(16), including controlled substances except narcotics, but shall be limited to only those agents related to the diagnosis and treatment of mental and emotional disorders as defined in R.S. 37:2352(5).
Medical Practice Act or the Act- R.S. 37:1261-92 as may be amended from time to time.
Medication- is synonymous with drug, as defined herein.
Medical Psychologist or MP-a psychological practitioner who has undergone specialized training in clinical psychopharmacology, passed a national proficiency examination in psychopharmacology approved by the board and holds a current license to practice medical psychology in this state, duly issued by the board.
Medical Psychology Practice Act, or MP Act-Acts 2009, No. 251, R.S. 37:1360.51-1360.72.
Narcotics-natural and synthetic opioid analgesics, and their derivatives used to relieve pain.
Physician- an individual lawfully entitled to engage in the practice of medicine in this state as evidenced by a current license duly issued by the board.
Primary or Attending Physician-a physician who has an active clinical relationship with a patient and is: principally responsible for the health care needs of the patient; or currently attending to the health care needs of the patient; or considered by the patient to be his or her primary or attending physician.
Psychopharmacologic Management-the treatment and/or management of mental or emotional disorders with medication.
AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1270(A)(1), 1270(B)(6) and 37:2371-2378.
